Agentix Corp AGTX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.03
- Day Range
- $0.03–0.03
- 52-Week Range
- $0.03–0.20
- Bid/Ask
- $0.03 / $0.10
- Market Cap
- $1.28 Mil
- Volume/Avg
- 301 / 2,608
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Agentix Corp is a biotechnology company. It is engaged in the development and commercialization of novel therapeutics to treat metabolic diseases, peripheral neuropathy, progressive lung disease, and ischemic reperfusion injury. Its principal business objective is to develop both science-driven synthetic and natural cannabinoid therapeutics that address unmet medical needs and continue to drive innovations in the endocannabinoid space.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.agentixcorp.com
Valuation
|
Metric
|
AGTX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
AGTX
Financial Strength
|
Metric
|
AGTX
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.11 |
Interest Coverage | — |
Quick Ratio
AGTX
Profitability
|
Metric
|
AGTX
|
|---|---|
Return on Assets (Normalized) | −656.72% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
AGTX
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Jyxb | $451.0 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Vjrdzq | $91.3 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Sxgnpd | $89.4 Bil | |
SGEN
| Seagen Inc Ordinary Shares | Ybqlsh | $40.7 Bil | |
MRNA
| Moderna Inc | Yrhx | $29.8 Bil | |
ARGX
| argenx SE ADR | Bxzp | $27.8 Bil | |
BNTX
| BioNTech SE ADR | Rrhv | $23.5 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Yssml | $21.4 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Spchlm | $17.6 Bil | |
INCY
| Incyte Corp | Vxvwm | $12.3 Bil |